Myocardial blood flow and glucose metabolism in diabetes mellitus

American Journal of Cardiology

Volumn 80, Issue 3 A, 1997, Pages 94A-101A

  Meyer, Christian ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; DOG; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030747020     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00463-3     Document Type: Conference Paper

References (72)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham Study. Diabetes. 23:1974;105-111.
2. Kannel WB. Diabetes and cardiovascular disease. JAMA. 241:1979;2035-2038.
3. Factor SM, Segal BH, van Hoeven KH. Diabetes and coronary artery disease. Coron Artery Dis. 3:1992;4-10.
4. Sutherland CG, Fisher BM, Frier BM, Dargie HJ, More IA, Lindop GB. Endomyocardial biopsy pathology in insulin-dependent diabetic patients with abnormal ventricular function. Histopathology. 166:1989;593-602.
5. Yarom R, Zirkin H, Stammler G, Rose AG. Human coronary microvessels in diabetes and ischaemia: morphometric study of autopsy material. J Pathol. 166:1992;265-270.
6. Tasca C, Stefaneanu L, Vasilescu C. The myocardial microangiopathy in human and experimental diabetes mellitus: a microscopic, ultrastructural, morphometric and computer-assisted symbolic-logic analysis. Endocrinologie. 24:1986;59-69.
7. Lee JC, Downing SE. Coronary dynamics and myocardial metabolism in the diabetic newborn lamb. Am J Physiol. 237:1979;H118-H124.
8. Durante W, Sunahara FA, Amar KS. Effect of diabetes on metabolic coronary dilatation. Cardiovas Res. 23:1989;40-45.
9. Sebbag L, Forrat R, Canet E, Wiernsperger N, Delaye J, Renaud S, De Lorgeril M. Effect of experimental non-insulin requiring diabetes on myocardial microcirculation during ischaemia in dogs. Eur J Clin Invest. 24:1994;686-690.
10. Kersten JR, Brooks LA, Dellsperger KC. Impaired microvascular response to graded coronary occlusion in diabetic and hyperglycemic dogs. Am J Physiol. 268:1995;H1667-H1674.
11. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 42:1993;1017-1025.
12. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation. 91:1995;635-640.
13. Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J. 118:1989;1000-1011.
14. Fisher BM, Frier BM. Evidence for a specific heart disease in diabetes in humans. Diabet Med. 7:1990;478-489.
15. Lapa AS, Regan T. Direct effects of diabetes on heart muscle. Coron Artery Dis. 3:1992;42-47.
16. De Fronzo RA. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. Coron Artery Dis. 3:1992;11-25.
17. Schelbert HR. Blood flow and metabolism by PET. Cardiol Clin. 12:1994;303-315.
18. Schwaiger M. Myocardial perfusion imaging with PET. J Nucl Med. 35:1994;693-698.
19. Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, Deeb M, Wolfe E, Wieland DM. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation. 82:1990;457-464.
20. Mullani NA, Volkow ND. Positron emission tomography instrumentation: a review and update. Am J Physiol Imaging. 314:1992;121-135.
21. Hutchins GD, Schwaiger M, Wolfe E. Positron emission tomography to quantitate myocardial perfusion. Am J Card Imaging. 7:1993;283-293.
22. Zoneraich S. Angina pectoris in diabetic patients with normal coronary arteries. JAMA. 234:1979;241-251.
23. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis. 27:1985;255-270.
24. Rubler S, Dlugash J, Yuceoglu YZ. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 30:1972;595-602.
25. Giles TD, Sander GE. Myocardial disease in hypertensive-diabetic patients. Am J Med. 87:1989;23S-28S.
26. Attali JR, Sachs RN, Valensi P, Palsky D, Lancrenan S, Tellier PH, Fermanian J, Vulpillat M, Lanfranchi J, Sebaoun J. Asymptomatic diabetic cardiomyopathy: a noninvasive study. Diabetes Res Clin Pract. 4:1988;183-190.
27. Koltai MZ, Wagner M, Pogásta G. Altered hyperemic response of the coronary arterial bed in alloxan-diabetes. Experientia. 39:1983;738-740.
28. Matsunaga T, Okumura K, Ishizaka H, Tsunoda R, Tayama S, Tabuchi T, Yasue H. Impairment of coronary blood flow regulation by endothelium derived nitric oxide in dogs with alloxan induced diabetes. J Cardiovasc Pharmacol. 28:1996;60-67.
29. Yamamoto J, Nakai M. Coronary hemodynamics in diabetic spontaneously hypertensive rats. Clin Exp Hypertens A. 12:1990;325-342.
30. 2 in experimental diabetes. Am J Physiol. 243:1982;H252-H258.
31. Baron AD. Hemodynamic actions of insulin. Am J Physiol. 267:1994;E187-E202.
32. Elliott TG, Viberti G. Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal. Baillieres Clin Endocrinol Metab. 7:1993;1079-1103.
33. Shoemaker JK, Bonen A. Vascular actions of insulin in health and disease. Can J Appl Physiol. 20:1995;127-154.
34. Wiernsperger N. Vascular defects in the aetiology of peripheral insulin resistance in diabetes. A critical review of hypotheses and facts. Diabetes Metab Rev. 10:1994;287-307.
35. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest. 85:1990;1844-1852.
36. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 87:1991;2246-2252.
37. Bennett WM, Connacher AA, Scrimgeour CM, Jung RT, Rennie MJ. Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissues during hyperaminoacidemia. Am J Physiol. 259:1990;E185-E194.
38. Creager MS, Liang CS, Coffman JD. β adrenergic mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther. 235:1985;709-714.
39. Gelfand RA, Barrett EJ. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J Clin Invest. 80:1987;1-6.
40. Randin D, Vollenweider P, Tappy L, Jequier E, Nicod P, Scherrer U. Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol. 266:1994;R809-R816.
41. Vollenweider P, Tappy L, Randin D, Schneiter P, Jequier E, Nicod P, Scherrer U. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest. 92:1993;147-154.
42. Ferrannini E, Vichi S, Natali A, Severi S. Cardiac disease in diabetic patients. J Cardiovasc Pharmacol. 28:1996;S16-S22.
43. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 334:1996;952-957.
44. Hackel DB. Effect of insulin on cardiac metabolism of intact normal dogs. Am J Physiol. 199:1960;1135-1138.
45. Downing SE, Lee JC, Rieker RP. Mechanical and metabolic effects of insulin on newborn lamb myocardium. Am J Obstet Gynecol. 127:1977;649-656.
46. Downing SE, Lee JC. Myocardial and coronary vascular responses to insulin in the diabetic lamb. Am J Physiol. 237:1979;H514-H519.
47. Downing SE, Lee JC, Matisoff DN. Coronary blood flow in the diabetic lamb with metabolic acidosis. Am J Physiol. 238:1980;H263-H268.
48. Liang C, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB Jr. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest. 69:1982;1321-1336.
49. Barrett EJ, Schwartz RG, Francis CK, Zaret BL. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest. 74:1984;1073-1079.
50. Thomassen A, Nielsen TT, Bagger JP, Henningsen P. Cardiac metabolic and hemodynamic effects of insulin in patients with coronary artery disease. Diabetes. 38:1989;1175-1180.
51. Ferrannini E, Santoro D, Bonadonna R, Natali A, Parodi O, Camici PG. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol. 264:1993;E308-E315.
52. Rogers WJ, Russell RO Jr, McDaniel HG, Rackley CE. Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man. Am J Cardiol. 40:1977;421-428.
53. Wilson RA, Okada RD, Strauss HW, Pohost GM. Effect of glucose-insulin-potassium infusion on thallium myocardial clearance. Circulation. 68:1983;203-209.
54. Groeneveld AB, van Lambalgen AA, van den Bos GC, Nauta JJ, Thijs LG. Metabolic vasodilatation with glucose-insulin-potassium does not change the heterogeneous distribution of coronary blood flow in the dog. Cardiovasc Res. 26:1992;757-764.
55. Camici P, Ferranini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis. 32:1989;217-238.
56. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teras M, Haaparanta M, Bergman J, Solin O, Voipio Pulkki LM, Wegelius U, Yki-Järvinen H. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest. 89:1992;1767-1774.
57. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 hours in patients with NIDDM. Diabetes. 37:1988;1020-1024.
58. Falholt K, Jensen I, Lindkaer Jensen S, Mortensen H, Volund A, Heding LG, Noerskov Petersen P, Falholt W. Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabetic Med. 5:1987;27-31.
59. Nuutila P, Knuuti MJ, Raitakari M, Ruotsalainen U, Teras M, Voipio Pulkki LM, Haaparanta M, Solin O, Wegelius U, Yki Jarvinen H. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol. 267:1994;E941-E946.
60. Knuuti MJ, Maki M, Yki Jarvinen H, Voipio Pulkki LM, Harkonen R, Haaparanta M, Nuutila P. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol. 27:1995;1359-1367.
61. Nuutila P, Knuuti MJ, Maki M, Laine H, Ruotsalainen U, Teras M, Haaparanta M, Solin O, Yki Jarvinen H. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes. 44:1995;31-36.
62. Nuutila P, Knuuti MJ, Heinonen OJ, Ruotsalainen U, Teras M, Bergman J, Solin O, Yki Jarvinen H, Voipio Pulkki LM, Wegelius U, Koivisto VA. Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle. J Clin Invest. 93:1994;2267-2274.
63. DeFronzo RA. The triumvirate: β -cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 37:1988;667-687.
64. Greene DA, Lattimer SA, Sima AAF. Sorbitol phosphoinositides and sodium-potassium ATPase in the pathogenesis of diabetic complications. N Engl J Med. 316:1987;599-606.
65. Vom Dahl J, Hicks RJ, Lee KS. Positron emission tomography myocardial viability studies in patients with diabetes mellitus. (Abstr.). J Am Coll Cardiol. 17:1991;121A.
66. Lee KS, vom Dahl J, Hicks RJ, Schwaiger M. Relationship between blood glucose levels and F-18-fluorodeoxyglucose image quality in cardiac PET-FDG studies(Abstr.). J Am Coll Cardiol. 17:1991;120A.
67. vom Dahl J, Herman WH, Hicks RJ, Ortiz Alonso FJ, Lee KS, Allman KC, Wolfe ER Jr, Kalff V, Schwaiger M. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation. 88:1993;395-404.
68. Nuutila P, Knuuti J, Ruotsalainen U, Koivisto VA, Eronen E, Teras M, Bergman J, Haaparanta M, Voipio Pulkki LM, Viikari J, Ronnema T, Wegelius U, Yki-Järvinen H. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Physiol. 264:1993;E756-E762.
69. Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA. Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-restistant type I diabetic patients. Diabetes. 39:1990;157-167.
70. Morgan HE, Cadenas E, Regen DM, Park CR. Regulation of glucose uptake in muscle. II. Rate-limiting steps and effects of insulin and anoxia in heart muscle from diabetic rats. J Biol Chem. 236:1961;262-268.
71. Voipio Pulkki LM, Nuutila P, Knuuti MJ, Ruotsalainen U, Haaparanta M, Teras M, Wegelius U, Koivisto VA. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med. 34:1993;2064-2067.
72. Monti LD, Lucignani G, Landoni C, Moresco RM, Piatti P, Stefani I, Pozza G, Fazio F. Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels. Diabetes. 44:1995;537-542.